“CRISPR-Cas9 Genomic Editing As an Innovation in the Management of Sickle Cell Disease: A Systematic Review”. American Journal of Medical Science and Innovation 2, no. 2 (July 31, 2023): 44–56. Accessed August 2, 2026. https://www.e-pallipublishers.com/index.php/ajmsi/article/view/1760.